Myriad Genetics Inc
NASDAQ:MYGN
Myriad Genetics Inc
Other Liabilities
Myriad Genetics Inc
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Myriad Genetics Inc
NASDAQ:MYGN
|
Other Liabilities
$165.7m
|
CAGR 3-Years
19%
|
CAGR 5-Years
35%
|
CAGR 10-Years
28%
|
|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
24%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$6.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
See Also
What is Myriad Genetics Inc's Other Liabilities?
Other Liabilities
165.7m
USD
Based on the financial report for Mar 31, 2024, Myriad Genetics Inc's Other Liabilities amounts to 165.7m USD.
What is Myriad Genetics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
28%
Over the last year, the Other Liabilities growth was -11%. The average annual Other Liabilities growth rates for Myriad Genetics Inc have been 19% over the past three years , 35% over the past five years , and 28% over the past ten years .